Ben S Ou
Overview
Explore the profile of Ben S Ou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ou B, Baillet J, Filsinger Interrante M, Adamska J, Zhou X, Saouaf O, et al.
Sci Adv
. 2024 Aug;
10(32):eadn7187.
PMID: 39110802
Over the past few decades, the development of potent and safe immune-activating adjuvant technologies has become the heart of intensive research in the constant fight against highly mutative and immune...
2.
Meany E, Klich J, Jons C, Mao T, Chaudhary N, Utz A, et al.
bioRxiv
. 2024 Jul;
PMID: 39026835
Messenger RNA (mRNA) delivered in lipid nanoparticles (LNPs) rose to the forefront of vaccine candidates during the COVID-19 pandemic due in part to scalability, adaptability, and potency. Yet there remain...
3.
Ou B, Baillet J, Picece V, Gale E, Powell A, Saouaf O, et al.
ACS Nano
. 2024 Jan;
18(4):3214-3233.
PMID: 38215338
Development of effective vaccines for infectious diseases has been one of the most successful global health interventions in history. Though, while ideal subunit vaccines strongly rely on antigen and adjuvant(s)...
4.
Ou B, Baillet J, Filsinger Interrante M, Adamska J, Zhou X, Saouaf O, et al.
bioRxiv
. 2023 Aug;
PMID: 37577608
Teaser: Saponin-TLRa nanoadjuvants provide distinct immune signatures and drive potent, broad, durable COVID-19 and HIV vaccine responses.
5.
Ou B, Saouaf O, Yan J, Bruun T, Baillet J, Zhou X, et al.
Adv Healthc Mater
. 2023 Jun;
12(28):e2301495.
PMID: 37278391
Most vaccines require several immunizations to induce robust immunity, and indeed, most SARS-CoV-2 vaccines require an initial two-shot regimen followed by several boosters to maintain efficacy. Such a complex series...
6.
Yan J, Ou B, Saouaf O, Meany E, Eckman N, Appel E
bioRxiv
. 2023 Mar;
PMID: 36993717
Equitable global access to vaccines requires we overcome challenges associated with complex immunization schedules and their associated economic burdens that hinder delivery in under resourced environments. The rabies vaccine, for...
7.
Ou B, Saouaf O, Baillet J, Appel E
Adv Drug Deliv Rev
. 2022 Jun;
187:114401.
PMID: 35750115
The immune system is one of the most important, complex biological networks regulating and protecting human health. Its precise modulation can prevent deadly infections and fight cancer. Accordingly, prophylactic vaccines...
8.
Grosskopf A, Labanieh L, Klysz D, Roth G, Xu P, Adebowale O, et al.
Sci Adv
. 2022 Apr;
8(14):eabn8264.
PMID: 35394838
Adoptive cell therapy (ACT) has proven to be highly effective in treating blood cancers, but traditional approaches to ACT are poorly effective in treating solid tumors observed clinically. Novel delivery...
9.
Gale E, Powell A, Roth G, Meany E, Yan J, Ou B, et al.
Adv Mater
. 2021 Oct;
33(51):e2104362.
PMID: 34651342
The development of effective vaccines that can be rapidly manufactured and distributed worldwide is necessary to mitigate the devastating health and economic impacts of pandemics like COVID-19. The receptor-binding domain...
10.
Roth G, Picece V, Ou B, Luo W, Pulendran B, Appel E
Nat Rev Mater
. 2021 Oct;
7(3):174-195.
PMID: 34603749
Vaccines are the key technology to combat existing and emerging infectious diseases. However, increasing the potency, quality and durability of the vaccine response remains a challenge. As our knowledge of...